Austin Mishko, DPM
Foot & Ankle Surgery · Washington, NJNPI 1871114876
Payments from drug & device makers
Across 70 payments — averaging $122.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$2K
- Stryker$2K
- Novus Surgical Solutions LLC$1K
- Trimed, Inc.$1K
- Novus Surgical Consultants$755
- Arthrex$624
- plus $1K from 13 others
What the payments were for
- Travel & lodging$3,43040%
- Food & beverage$3,95346%
- Education$1,20014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 17 | $1,968 |
| Stryker | 10 | $1,533 |
| Novus Surgical Solutions LLC | 4 | $1,422 |
| Trimed, Inc. | 2 | $1,028 |
| Novus Surgical Consultants | 11 | $755 |
| Arthrex | 8 | $624 |
| Amgen | 2 | $249 |
| Integra Lifesciences Corporation | 2 | $133 |
| Cerapedics Inc. | 1 | $131 |
| Forma Medical | 1 | $127 |
| Smith+Nephew | 3 | $125 |
| Bone Support Inc. | 1 | $90 |
| DJO, LLC | 1 | $89 |
| AbbVie | 1 | $88 |
| Biocomposites Inc | 1 | $74 |
| Johnson & Johnson | 1 | $56 |
| Treace Medical Concepts, Inc. | 2 | $35 |
| KCI USA, Inc. | 1 | $35 |
| Zimmer Biomet | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$2,921
- PROstep$815
- AUGMENT INJECTABLE$422
- INTEGRA$351
- BIOFOAM$275
- KRYSTEXXA$249
- CITREFIX$140
- 7 X 23MM CITRELOCK IMPLANT$140
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$131
- OptimalAkin$127
- SALVATION$117
- INTEGRA DERMAL REGENERATION TEMPLATE$117
- PRIMATRIX$117
How this compares
$8,583 in reported general payments places this provider in the 80th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 21 | $430 |
| Terbinafine Hcl | 19 | $354 |
| Cephalexin | 34 | $240 |
| Gabapentin | 23 | $227 |
| Meloxicam | 82 | $201 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Washington
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.